Market

EBITDA up 51 per cent at Rs 462 crores, net profit (excluding exceptional item) up 86 per cent at Rs 223 crores, small molecules…

Growth is attributed to revenues derived from niche businesses of complex generics and Contract Development and Manufacturing…

Glenmark will manufacture and supply Remogliflozin while Torrent will market the drug under its own trademark 'Zucator' in India…

Moderation in pricing pressure for the US market, new launches and market share gains for existing products and consolidation…

Over 300 turnkey exhibitors to participate in India’s most comprehensive Analytical, Lab, Pharma Machinery & Ingredients Trade…

A drug’s journey from initial conceptualisation to hitting the market place remains a costly, complex and time-consuming process…

The Global Drug Development (GDD) centre in Hyderabad, is one of the three major global development sites for Novartis. Arno…

More than 100 IT functionaries from manufacturing companies from across India participated at the event where role of IT in pharma…

The pharmaceutical sector has seen some high profile investigations and settlements concerning bribes given to healthcare…

Novartis’ acquisition of IFM Therapeutics contribute 27 per cent to the total deal value In April 2019, the healthcare industry…